Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Linifanib/mFOLFOX6 combination shows promise in metastatic colorectal cancer

July 15, 2010

ONO-5334 has beneficial effects on bone in postmenopausal women

July 15, 2010

Belatacept superior to ciclosporin in renal transplant recipients

July 15, 2010

Lorcaserin reduces body weight in phase III BLOOM/BLOSSOM trials

July 15, 2010

First-in-human data reported on CHF-5074 for AD

July 14, 2010

DegludecPlus effective in type 2 diabetes in proof-of-concept trial

July 14, 2010

Phase III data reveal effects of add-on dapagliflozin in poorly controlled diabetes

July 14, 2010

Ostarine increases lean body mass and leg strength in postmenopausal women

July 14, 2010

Viamet describes new cytochrome P450-C17 inhibitors

July 13, 2010

Exelixis presents preclinical data on agents investigated for diabetes

July 13, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...